Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 6;9(8):2129–2142. doi: 10.7150/thno.31179

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Ivyspring International Publisher

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.

PMC Copyright notice

A. Kaplan-Meier survival curve for the therapy and control groups. Square: ¹⁷⁷Lu-hu11B6, group A, with a median survival of 19 days. Triangle: ¹⁷⁷Lu-hu11B6, group B, uncensored (all animals), median survival 77 days; Cross: ¹⁷⁷Lu-hu11B6, group B, censored with a median survival beyond 120 days; Stars: unlabeled hu11B6 median survival 44 days; Circle: ¹⁷⁷Lu-non-specific mAb median survival 33 days; Diamond: Vehicle median survival 23 days. B. Hematopoietic toxicity for the therapy group NMRI-foxn1^nu/foxn1^nu. From dosimetry the absorbed dose to bone marrow was estimated to 7.2-8.8 Gy showing a nadir at about 12 days for white blood cells and 18 days for red blood cells where after recovery is seen. The absorbed dose to the tumor in this group was estimated to 56-68 Gy.